Own Sonic Healthcare shares? Here's a look at the state of its balance sheet

Fundamentals are becoming increasingly important again in this current investment landscape

| More on:
Doctor reading a file

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sonic is a healthcare giant that has built up a bastion of cash and assets over the years 
  • With the probability of economic risks increasing, we take a closer look at Sonic's balance sheet
  • In the last 12 months, the Sonic share price has slipped around 12%

The Sonic Healthcare Ltd (ASX: SHL) share price had a turbulent time in FY22. After surging to 52-week highs of $46.71 on 30 December, the company's shares then cratered to $32.22 by 8 March.

After a relief rally, Sonic was trading sideways until June, but has since walked back towards its yearly lows, as seen below.

TradingView Chart

The forward-looking climate demands more from companies in terms of cash (liquidity and working capital) management.

With that in mind, let's take a look at Sonic's balance sheet to gain some insight into how it might weather any potential economic storm.

Sonic balance sheet breakdown

The most recent snapshot of Sonic's financial health was supplied within its set of half-yearly accounts back in February.

At that time, the company had cash and marketable securities of $735.3 million, down 18% from the previous year.

Shareholder equity totalled $7.26 billion, made up of $12.5 billion in total assets and $5.24 billion in total liabilities.

Let's take a deeper dive into how Sonic is managing cash and working capital.

Sonic should meet its short-term obligations when they fall due. Short-term liabilities are covered 1.1x by short-term assets (current ratio). That's one check for the Sonic Healthcare share price.

Meanwhile, the ratio of debt to assets is 26%, meaning debt holders have financed Sonic's asset base by that amount.

The long-term debt to total capital ratio is 28% suggesting the company has low leverage. It also has around $1 billion in long-term lease obligations.

Further insights to consider for the Sonic share price

Linking the balance sheet with some figures on the income statement gives further insights.

Sonic turned over its inventory 6.3 times in H1 FY22 and generated 75 cents for every dollar invested into its asset base.

It also generated a 12% return on assets and return on invested capital of 16% for the half as well. This is well above the company's cost of capital of 7%.

From this data, we can make a few inferences. First, Sonic can cover its short-term obligations when they come due.

It also is lowly-leveraged, with debt making up less than 30% of its capital structure. That's important in a world of rising interest rates.

It is also generating a decent return on its assets and invested capital that is above what it costs to acquire that capital.

These could be defensible characteristics in the event of an economic downturn. Remember, the balance sheet illustrates the financial health of the company, and these ratios give further insights.

In the last 12 months, the Sonic share price has slipped 12% into the red.

Sonic's asset and liability growth since 2018 is plotted on the chart below.

TradingView Chart

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »